Benzinga | Aug 12, 2021 08:36AM EDT

Black Diamond Therapeutic Q2 EPS $(0.95) Down From $(0.41) YoY

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.95) per share. This is a 131.71 percent decrease over losses of $(0.41) per share from the same period last year.